N. Bannert and R. Kurth, Retroelements and the human genome: new perspectives on an old relation, Proc Natl Acad Sci, pp.14572-14581, 2004.

W. Seifarth, O. Frank, U. Zeilfelder, B. Spiess, A. D. Greenwood et al., Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray, J Virol, vol.79, pp.341-52, 2005.

O. Frank, M. Giehl, C. Zheng, R. Hehlmann, C. Leib-mösch et al., Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders, J Virol, vol.79, pp.10890-901, 2005.

H. Perron, L. Mekaoui, C. Bernard, F. Veas, I. Stefas et al., Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients, Biol Psychiatry, vol.64, pp.1019-1042, 2008.

E. Balada, M. Vilardell-tarrés, and J. Ordi-ros, Implication of human endogenous retroviruses in the development of autoimmune diseases, Int Rev Immunol, vol.29, pp.351-70, 2010.

S. Levet, J. Medina, J. Joanou, A. Demolder, N. Queruel et al., An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes, JCI Insight, vol.2, p.94387, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02059891

R. Douville, J. Liu, J. Rothstein, and A. Nath, Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis, Ann Neurol, vol.69, pp.141-51, 2011.

W. Li, M. H. Lee, L. Henderson, R. Tyagi, M. Bachani et al., Human endogenous retrovirus-K contributes to motor neuron disease, Sci Transl Med, vol.7, pp.307-153, 2015.

H. Perron, C. Geny, A. Laurent, C. Mouriquand, J. Pellat et al., Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles, Res Virol, vol.140, pp.551-61, 1989.

H. Perron, B. Lalande, B. Gratacap, A. Laurent, O. Genoulaz et al., Isolation of retrovirus from patients with multiple sclerosis, Lancet, vol.337, pp.862-865, 1991.

H. Perron, J. A. Garson, F. Bedin, F. Beseme, G. Paranhos-baccala et al., Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. the collaborative research group on multiple sclerosis, Proc Natl Acad Sci, vol.94, pp.7583-7591, 1997.

M. Sommerlund, G. Pallesen, A. Møller-larsen, H. J. Hansen, and S. Haahr, Retrovirus-like particles in an Epstein-Barr virus-producing cell line derived from a patient with chronic progressive myelopathy, Acta Neurol Scand, vol.87, pp.71-77, 1993.

A. Dolei, C. Serra, G. Mameli, M. Pugliatti, G. Sechi et al., Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients, Neurology, vol.58, pp.471-474, 2002.

J. A. Garson, P. W. Tuke, P. Giraud, G. Paranhos-baccala, and H. Perron, Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis, Lancet, vol.351, p.33, 1998.

S. Sotgiu, G. Arru, G. Mameli, C. Serra, M. Pugliatti et al., Multiple sclerosis-associated retrovirus in early multiple sclerosis: a sixyear follow-up of a Sardinian cohort, Mult Scler, vol.12, pp.698-703, 2006.

P. Küry, A. Nath, A. Créange, A. Dolei, P. Marche et al., Human endogenous retroviruses in neurological diseases, Trends Mol Med, vol.24, pp.379-94, 2018.

N. Sutkowski, B. Conrad, D. A. Thorley-lawson, and B. T. Huber, Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen, Immunity, vol.15, pp.579-89, 2001.

G. Mameli, L. Poddighe, A. Mei, E. Uleri, S. Sotgiu et al., Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis, PLoS ONE, vol.7, p.44991, 2012.

A. K. Tai, J. Luka, D. Ablashi, and B. T. Huber, HHV-6A infection induces expression of HERV-K18-encoded superantigen, J Clin Virol, vol.46, pp.47-55, 2009.

V. L. Turcanova, B. Bundgaard, and P. Höllsberg, Human herpesvirus-6B induces expression of the human endogenous retrovirus K18-encoded superantigen, J Clin Virol, vol.46, pp.15-24, 2009.

S. Fernández-menéndez, M. Fernández-morán, I. Fernández-vega, A. Pérez-Álvarez, and J. Villafani-echazú, Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies, J Neurol Sci, vol.361, pp.213-222, 2016.

A. Pormohammad, T. Azimi, F. Falah, and E. Faghihloo, Relationship of human herpes virus 6 and multiple sclerosis: A systematic review and meta-analysis, J Cell Physiol, vol.233, pp.2850-62, 2018.

F. Santoro, P. E. Kennedy, G. Locatelli, M. S. Malnati, and E. A. Berger, CD46 is a cellular receptor for human herpesvirus 6, Cell, vol.99, pp.817-844, 1999.

T. Seya, J. R. Turner, and J. P. Atkinson, Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b, J Exp Med, vol.163, pp.837-55, 1986.

L. Friec, G. Sheppard, D. Whiteman, P. Karsten, C. M. Shamoun et al., The CD46-Jagged1 interaction is critical for human TH1 immunity, Nat Immunol, vol.13, pp.1213-1234, 2012.

J. M. Reynaud and B. Horvat, Human Herpesvirus 6 and Neuroinflammation, ISRN Virol, p.834890, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00972063

R. Cattaneo, Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet, J Virol, vol.78, pp.4385-4393, 2004.

J. Villaudy, M. Wencker, N. Gadot, N. A. Gillet, J. Scoazec et al., HTLV-1 propels thymic human T cell development in "human immune system" Rag2 ? / ? gamma c ? / ? mice, PLoS Pathog, vol.7, 2011.

K. Hashimoto, N. Ono, H. Tatsuo, H. Minagawa, M. Takeda et al., SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein, J Virol, vol.76, pp.6743-6752, 2002.

M. Takeda, K. Takeuchi, N. Miyajima, F. Kobune, Y. Ami et al., Recovery of pathogenic measles virus from cloned cDNA, J Virol, vol.74, pp.6643-6650, 2000.

M. Manchester, M. K. Liszewski, J. P. Atkinson, and M. B. Oldstone, Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus, Proc Natl Acad Sci USA, vol.91, pp.2161-2166, 1994.

C. J. Buchholz, D. Koller, P. Devaux, C. Mumenthaler, J. Schneider-schaulies et al., Mapping of the primary binding site of measles virus to its receptor CD46, J Biol Chem, vol.272, pp.22072-22081, 1997.

D. Naniche, T. F. Wild, C. Rabourdin-combe, and D. Gerlier, A monoclonal antibody recognizes a human cell surface glycoprotein involved in measles virus binding, J Gen Virol, pp.2617-2641, 1992.

B. L. Hsi, C. J. Yeh, P. Fénichel, M. Samson, and C. Grivaux, Monoclonal antibody GB24 recognizes a trophoblast-lymphocyte cross-reactive antigen, Am J Reprod Immunol Microbiol, vol.18, pp.21-28, 1988.

D. Sirena, B. Lilienfeld, M. Eisenhut, S. Kälin, K. Boucke et al., The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3, J Virol, vol.78, pp.4454-62, 2004.

J. C. Marie, A. L. Astier, P. Rivailler, C. Rabourdin-combe, T. F. Wild et al., Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation, Nat Immunol, vol.3, pp.659-66, 2002.
URL : https://hal.archives-ouvertes.fr/hal-02322420

M. B. Villiers, C. L. Villiers, A. M. Laharie, and P. N. Marche, Amplification of the antibody response by C3b complexed to antigen through an ester link, J Immunol, vol.162, pp.3647-52, 1999.

F. Curtin, H. Perron, A. Kromminga, H. Porchet, and A. B. Lang, Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein, mAbs, vol.7, pp.265-75, 2015.

D. Toullec, P. Pianetti, H. Coste, P. Bellevergue, T. Grand-perret et al., The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C, J Biol Chem, vol.266, pp.15771-81, 1991.

M. Yamada, S. Katsuma, T. Adachi, A. Hirasawa, S. Shiojima et al., Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis, Proc Natl Acad Sci, vol.102, pp.7736-7777, 2005.

P. E. Joubert, G. Meiffren, I. P. Grégoire, G. Pontini, C. Richetta et al., Autophagy induction by the pathogen receptor CD46, Cell Host Microbe, vol.6, pp.354-66, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-00456148

G. Mameli, L. Poddighe, V. Astone, G. Delogu, G. Arru et al., Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis, J Virol Methods, vol.161, pp.98-106, 2009.

K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods San Diego Calif, vol.25, pp.402-410, 2001.

A. L. Astier, G. Meiffren, S. Freeman, and D. A. Hafler, Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis, J Clin Invest, vol.116, pp.3252-3259, 2006.
URL : https://hal.archives-ouvertes.fr/hal-02322380

S. A. Bustin, V. Benes, J. A. Garson, J. Hellemans, J. Huggett et al., The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments, Clin Chem, vol.55, pp.611-633, 2009.

H. Tang, S. Serada, A. Kawabata, M. Ota, E. Hayashi et al., CD134 is a cellular receptor specific for human herpesvirus-6B entry, Proc Natl Acad Sci, vol.110, pp.9096-9105, 2013.

H. L. Greenstone, F. Santoro, P. Lusso, and E. A. Berger, Human herpesvirus 6 and measles virus employ distinct CD46 domains for receptor function, J Biol Chem, vol.277, pp.39112-39120, 2002.

E. M. Adams, M. C. Brown, M. Nunge, M. Krych, and J. P. Atkinson, Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity, J Immunol, vol.147, pp.3005-3016, 1991.

M. K. Liszewski, M. Leung, W. Cui, V. B. Subramanian, J. Parkinson et al., Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46), J Biol Chem, vol.275, pp.37692-701, 2000.

H. Yamamoto, A. F. Fara, P. Dasgupta, and C. Kemper, CD46: the "multitasker" of complement proteins, Int J Biochem Cell Biol, vol.45, pp.2808-2828, 2013.

J. Oliaro, A. Pasam, N. J. Waterhouse, K. A. Browne, M. J. Ludford-menting et al., Ligation of the cell surface receptor, CD46, alters T cell polarity and response to antigen presentation, Proc Natl Acad Sci, vol.103, pp.18685-90, 2006.

Y. Zaffran, O. Destaing, A. Roux, S. Ory, T. Nheu et al., CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase, J Immunol, vol.167, pp.6780-6785, 2001.
URL : https://hal.archives-ouvertes.fr/hal-02322447

G. Wang, M. K. Liszewski, A. C. Chan, and J. P. Atkinson, Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation, J Immunol, vol.164, pp.1839-1885, 2000.

M. K. Liszewski, C. Kemper, J. D. Price, and J. P. Atkinson, Emerging roles and new functions of CD46, Springer Semin Immunopathol, vol.27, pp.345-58, 2005.

A. Duperray, D. Barbe, G. Raguenez, B. B. Weksler, I. A. Romero et al., Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4, Int Immunol, vol.27, pp.545-53, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01163817

D. Kremer, T. Schichel, M. Förster, N. Tzekova, C. Bernard et al., Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation, Ann Neurol, vol.74, pp.721-753, 2013.

A. Rolland, E. Jouvin-marche, C. Viret, M. Faure, H. Perron et al., The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses, J Immunol, vol.176, pp.7636-7680, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00000108

A. Madeira, I. Burgelin, H. Perron, F. Curtin, A. B. Lang et al., MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: relevance of GNbAC1 in multiple sclerosis treatment, J Neuroimmunol, vol.291, pp.29-38, 2016.

F. C. Hsiao, M. Lin, A. Tai, G. Chen, and B. T. Huber, Cutting edge: epstein-barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells, J Immunol, vol.177, pp.2056-60, 2006.

A. S. Hansen, B. B. Bundgaard, B. K. Møller, and P. Höllsberg, Non-random pairing of CD46 isoforms with skewing towards BC2 and C2 in activated and memory/effector T cells, Sci Rep, vol.6, p.35406, 2016.

M. Iacobelli-martinez and G. R. Nemerow, Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses, J Virol, vol.81, pp.1305-1317, 2007.

D. Gerlier, M. C. Trescol-biémont, G. Varior-krishnan, D. Naniche, I. Fugier-vivier et al., Efficient major histocompatibility complex class IIrestricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cells, J Exp Med, vol.179, pp.353-361, 1994.

P. Rivailler, M. C. Trescol-biemont, C. Gimenez, C. Rabourdin-combe, and B. Horvat, Enhanced MHC class II-restricted presentation of measles virus (MV) hemagglutinin in transgenic mice expressing human MV receptor CD46, Eur J Immunol, vol.28, pp.1301-1315, 1998.

S. W. Lee, R. A. Bonnah, D. L. Higashi, J. P. Atkinson, S. L. Milgram et al., CD46 is phosphorylated at tyrosine 354 upon infection of epithelial cells by Neisseria gonorrhoeae, J Cell Biol, vol.156, pp.951-958, 2002.

M. J. Ludford-menting, S. J. Thomas, B. Crimeen, L. J. Harris, B. E. Loveland et al., A functional interaction between CD46 and DLG4: a role for DLG4 in epithelial polarization, J Biol Chem, vol.277, pp.4477-84, 2002.

J. Cardone, L. Friec, G. Vantourout, P. Roberts, A. Fuchs et al., Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells, Nat Immunol, vol.11, pp.862-71, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00564091

S. S. Soldan, R. Berti, N. Salem, P. Secchiero, L. Flamand et al., Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA, Nat Med, vol.3, pp.1394-1401, 1997.

D. V. Ablashi, W. Lapps, M. Kaplan, J. E. Whitman, J. R. Richert et al., Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report, Mult Scler Houndmills Basingstoke Engl, vol.4, pp.490-496, 1998.

S. Chapenko, A. Millers, Z. Nora, I. Logina, R. Kukaine et al., Correlation between HHV-6 reactivation and multiple sclerosis disease activity, J Med Virol, vol.69, pp.111-118, 2003.

H. Perron, R. Germi, C. Bernard, M. Garcia-montojo, C. Deluen et al., Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease, Mult Scler Houndmills Basingstoke Engl, vol.18, pp.1721-1757, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00826751

A. L. Astier, T-cell regulation by CD46 and its relevance in multiple sclerosis, Immunology, vol.124, pp.149-54, 2008.
URL : https://hal.archives-ouvertes.fr/hal-02322284

J. Killick, G. Morisse, D. Sieger, and A. L. Astier, Complement as a regulator of adaptive immunity, Semin Immunopathol, vol.40, pp.37-48, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01593213

J. Reynaud, Développement d'un Modèle Murin Transgénique D'infection par L'herpèsvirus 6A et étude des Mécanismes D'induction de la Neuroinflammation, 2013.